VSTM Archived Articles
Verastem Oncology (NASDAQ:VSTM): A Resilient Biopharmaceutical Tackling RAS/MAPK-Driven Cancers
Published on March 11, 2025
Verastem, Inc. (NASDAQ:VSTM): A Precision Oncology Pioneer Unlocking New Frontiers in KRAS-Driven Cancers
Published on November 02, 2024